Area of research
Molecular Biology · Hematology
Research interest
Research interests include Amyloidosis: Diagnosis, Treatment, Outcomes, Multiple Myeloma Research and Treatments, Chronic Lymphocytic Leukemia Research, and Parathyroid Disorders and Treatments.
Protocol for high-throughput electron tomography exemplified on centrioles in primary human plasma cells
High-throughput electron tomography identifies centriole over-elongation as an early event in plasma cell disorders
A high-throughput electron tomography workflow reveals over-elongated centrioles in relapsed/refractory multiple myeloma
<scp>Daratumumab, lenalidomide, and dexamethasone</scp> in systemic <scp>light‐chain</scp> amyloidosis: High efficacy, relevant toxicity and main adverse effect of gain 1q21
Lenalidomide and dexamethasone in relapsed/refractory immunoglobulin light chain (AL) amyloidosis: results from a large cohort of patients with long follow‐up
Two-Year Evaluation of the German Clinical Amyloidosis Registry
Multi-Modality Imaging Reveals Structural Centrosome Aberrations As a Potential Driver of Chromosomal Instability in Early-Stage Plasma Cell Disorders
Daratumumab for systemic AL amyloidosis: prognostic factors and adverse outcome with nephrotic-range albuminuria
Performance analysis of AL amyloidosis cardiac biomarker staging systems with special focus on renal failure and atrial arrhythmia
A Semi-Automated Knime-Based Workflow for High Throughput Quantification and Analysis of Centrosome Aberrations
High-Throughput Immunofluorescence and Electron Tomography to Characterize Centrosomal Aberrations in Plasma Cell Neoplasia
Cytogenetic intraclonal heterogeneity of plasma cell dyscrasia in AL amyloidosis as compared with multiple myeloma
AL amyloidosis patients with low amyloidogenic free light chain levels at first diagnosis have an excellent prognosis